Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

Related Citations for PubMed (Select 23329063)

1.

Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Jnawali HN, Yoo H, Ryoo S, Lee KJ, Kim BJ, Koh WJ, Kim CK, Kim HJ, Park YK.

World J Microbiol Biotechnol. 2013 Jun;29(6):975-82. doi: 10.1007/s11274-013-1256-x. Epub 2013 Jan 18.

PMID:
23329063
2.

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.

Georghiou SB, Magana M, Garfein RS, Catanzaro DG, Catanzaro A, Rodwell TC.

PLoS One. 2012;7(3):e33275. doi: 10.1371/journal.pone.0033275. Epub 2012 Mar 29. Review.

3.

Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.

Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, Chung GT, Choe KH, Ryoo S.

Diagn Microbiol Infect Dis. 2013 Jun;76(2):187-96. doi: 10.1016/j.diagmicrobio.2013.02.035. Epub 2013 Apr 2.

PMID:
23561273
4.

Molecular characterization of amikacin, kanamycin and capreomycin resistance in M/XDR-TB strains isolated in Thailand.

Sowajassatakul A, Prammananan T, Chaiprasert A, Phunpruch S.

BMC Microbiol. 2014 Jun 22;14:165. doi: 10.1186/1471-2180-14-165.

5.

Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China.

Du Q, Dai G, Long Q, Yu X, Dong L, Huang H, Xie J.

Diagn Microbiol Infect Dis. 2013 Oct;77(2):138-42. doi: 10.1016/j.diagmicrobio.2013.06.031. Epub 2013 Aug 12.

PMID:
23948547
6.

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.

Jugheli L, Bzekalava N, de Rijk P, Fissette K, Portaels F, Rigouts L.

Antimicrob Agents Chemother. 2009 Dec;53(12):5064-8. doi: 10.1128/AAC.00851-09. Epub 2009 Sep 14.

7.

Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis.

Sirgel FA, Tait M, Warren RM, Streicher EM, Böttger EC, van Helden PD, Gey van Pittius NC, Coetzee G, Hoosain EY, Chabula-Nxiweni M, Hayes C, Victor TC, Trollip A.

Microb Drug Resist. 2012 Apr;18(2):193-7. doi: 10.1089/mdr.2011.0063. Epub 2011 Jul 6.

PMID:
21732736
8.

Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates.

Brossier F, Veziris N, Aubry A, Jarlier V, Sougakoff W.

J Clin Microbiol. 2010 May;48(5):1683-9. doi: 10.1128/JCM.01947-09. Epub 2010 Mar 24.

9.

Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment.

Feuerriegel S, Cox HS, Zarkua N, Karimovich HA, Braker K, Rüsch-Gerdes S, Niemann S.

Antimicrob Agents Chemother. 2009 Aug;53(8):3353-6. doi: 10.1128/AAC.00050-09. Epub 2009 May 26.

10.

Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.

Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, Jeon D, Min SY, Oh T, Kim Y, Kim YM, Rajan V, Wong SY, Shamputa IC, Carroll M, Goldfeder L, Lee SA, Holland SM, Eum S, Lee H, Barry CE 3rd.

J Clin Microbiol. 2010 Feb;48(2):402-11. doi: 10.1128/JCM.01476-09. Epub 2009 Dec 23.

11.

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations.

Rodwell TC, Valafar F, Douglas J, Qian L, Garfein RS, Chawla A, Torres J, Zadorozhny V, Kim MS, Hoshide M, Catanzaro D, Jackson L, Lin G, Desmond E, Rodrigues C, Eisenach K, Victor TC, Ismail N, Crudu V, Gler MT, Catanzaro A.

J Clin Microbiol. 2014 Mar;52(3):781-9. doi: 10.1128/JCM.02701-13. Epub 2013 Dec 18.

12.

Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.

Dymova MA, Cherednichenko AG, Alkhovik OI, Khrapov EA, Petrenko TI, Filipenko ML.

BMC Infect Dis. 2014 Sep 3;14:478. doi: 10.1186/1471-2334-14-478.

13.

Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.

Khanna A, Raj VS, Tarai B, Sood R, Pareek PK, Upadhyay DJ, Sharma P, Rattan A, Saini KS, Singh H.

Antimicrob Agents Chemother. 2010 Nov;54(11):4789-93. doi: 10.1128/AAC.00661-10. Epub 2010 Aug 16.

14.

Molecular characterization of multidrug- and extensively drug-resistant Mycobacterium tuberculosis strains in Jiangxi, China.

Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, Tu S.

J Clin Microbiol. 2012 Jul;50(7):2404-13. doi: 10.1128/JCM.06860-11. Epub 2012 May 2.

15.

Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.

Maus CE, Plikaytis BB, Shinnick TM.

Antimicrob Agents Chemother. 2005 Aug;49(8):3192-7.

16.

Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.

Sugawara I, Zhang J, Li C.

Indian J Exp Biol. 2009 Jun;47(6):520-2.

PMID:
19634718
17.

Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.

Zimenkov DV, Antonova OV, Kuz'min AV, Isaeva YD, Krylova LY, Popov SA, Zasedatelev AS, Mikhailovich VM, Gryadunov DA.

BMC Infect Dis. 2013 May 24;13:240. doi: 10.1186/1471-2334-13-240.

18.

Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.

Hu Y, Hoffner S, Wu L, Zhao Q, Jiang W, Xu B.

Antimicrob Agents Chemother. 2013 Aug;57(8):3857-63. doi: 10.1128/AAC.00102-13. Epub 2013 Jun 3.

19.

Genotypic and phenotypic characteristics of aminoglycoside-resistant Mycobacterium tuberculosis isolates in Latvia.

Bauskenieks M, Pole I, Skenders G, Jansone I, Broka L, Nodieva A, Ozere I, Kalvisa A, Ranka R, Baumanis V.

Diagn Microbiol Infect Dis. 2015 Mar;81(3):177-82. doi: 10.1016/j.diagmicrobio.2014.12.004. Epub 2014 Dec 15.

PMID:
25557624
20.

Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.

Perdigão J, Macedo R, Malaquias A, Ferreira A, Brum L, Portugal I.

J Antimicrob Chemother. 2010 Feb;65(2):224-7. doi: 10.1093/jac/dkp452. Epub 2009 Dec 22.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk